Author:
de Souza Jonas A.,Wong Yu-Ning
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. (2012) Medicare: High-Expenditure Part B Drugs. http://www.gao.gov/assets/650/649459.pdf . Accessed 4 Aug 2013
2. Schrag D (2004) The price tag on progress—chemotherapy for colorectal cancer. N Engl J Med 351(4):317–319
3. Wong YN, Meropol NJ, Speier W, Sargent D, Goldberg RM, Beck JR (2009) Cost implications of new treatments for advanced colorectal cancer. Cancer 115(10):2081–2091
4. Experts in chronic myeloid leukemia (2013) Price of drugs for chronic myeloid leukemia (CML), reflection of the unsustainable cancer drug prices: perspective of CML Experts. Blood 121(22):4439–4442
5. Prawitz AD, Garman ET, Sorhaindo B, O’Neill B, Kim J, Drentea P (2006) InCharge Financial Distress/Financial Well-Being Scale: development, administration, and score interpretation. Financ Couns Plan 17(1):34–50
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献